Niche MIS Advantage Paradigm has a long-standing focus on MIS autogenous bone grafting, with VisiCORE developed alongside leading Foot & Ankle surgeons. This positions the company to target orthopedic and trauma teams seeking improved graft visibility, precision, and efficiency.

GraftLOK Differentiator GraftLOK reduces over-harvesting and graft loss by enabling simpler surgical technique and potential cost savings on bone substitutes. These benefits resonate with OR teams, surgical planners, and materials management seeking improved patient outcomes and lower procedure costs.

Channel Growth Being a specialized yet small company creates opportunities to partner with orthopedic distributors, academic centers, and hospital networks to accelerate adoption and scale revenue. Leveraging co-development, clinical pilots, and reference sites can help expand into new markets.

Digital Marketing Potential Paradigm’s modern web and analytics stack supports targeted lead generation and content marketing. Focused campaigns toward Foot and Ankle and spine surgeons, backed by case studies and ROI data, can drive trials and new accounts.

Market Positioning Despite competition from larger medical device firms, Paradigm can win through niche MIS grafting solutions, strong surgeon collaboration, and outcome-centric messaging. Building a champion network among surgeons and facilities can speed adoption across the patient care continuum.